Xenetic Biosciences Enters Into Manufacturing Agreement With Catalent Pharma Solutions
editor In full transparency, the following is a press release *** FRAMINGHAM – Xenetic Biosciences, Inc., a biopharmaceutical company focused on advancing innovative immune-oncology technologies addressing hard-to-treat cancers, yesterday, July 7,…